Embedded Files
ROUND TABLE I Psychedelics in Therapy: clinical challenges and opportunities
Chairs:
Mauro D’Alonzo, Società Italiana Medicina Psichedelica (SIMEPSI);
Gabriele Penazzi, University of Trento
Pierluigi Simonato, University of Hertfordshire, Dual Dignosis Clinic Parco dei Tigli Padova
Matteo Buonarroti, Società Italiana Medicina Psichedelica (SIMEPSI)
Tommaso Barba, Centre for Psychedelic Research, Imperial College London
Federico Seragnoli, Hôpitaux universitaires de Genève
Tania Re, University of Genova
Sofia Venturini, University of Maastricht
ROUND TABLE II: Psychedelics in Therapy: legal and ethical issue
Legal Status of Psychedelics and Impact in Research and Development
Tadeusz Hawrot, Psychedelic Access and Research European Alliance (PAREA)
ROUND TABLE II: Psychedelics in Therapy: legal and ethical issue
The Sleeping Beauty of Human Rights: the right to science
Marco Perduca, Luca Coscioni Association
ROUND TABLE II: Psychedelics in Therapy: legal and ethical issue
Psychedelic Drugs in Psychiatry: a European regulatory perspective
Marion Haberkamp
European Medicine Agency (EMA)
ROUND TABLE II: Psychedelics in Therapy: legal and ethical issue
Ensuring Ethical Standards in Psychedelic Research: Insights from Horizon Europe Funding Programme
Carla Giuffrè
EU Legal and Ethics Consultant
ROUND TABLE III: Psychedelic Therapy: where next?
Chairs:
Nicola De Pisapia, University of Trento,
Ornella Corazza, University of Trento, University of Hertfordshire
Benyamina Amine, Paul Brousse Hospital, Villejuif, France; Université Paris Sud- APHP, Université Paris Saclay, Le Kremlin Bicêtre
Gianluca Esposito, University of Trento
Kim Kuypers, Maastricht University
Rick Doblin, MAPS
Marion Haberkamp, European Medicine Agency (EMA)
Latest Clinical and Neuromechanistic Data from Imperial College’s Psychedelic Research Program
Matthias E. Liechti
Division of Clinical Pharmacology and Toxicology, University Hospital Basel
The Use of Psychedelics in Addiction Treatment: where are we now?
Benyamina Amine
Paul Brousse Hospital, Villejuif, France;
Université Paris Sud- APHP, Université Paris Saclay, Le Kremlin Bicêtre
The Evolution of Psychedelic Studies (1965-2024): A data-driven exploration of scientific milestones and emerging themes
Gianluca Esposito
University of Trento
Latest Clinical and Neuromechanistic Data from Imperial College’s Psychedelic Research Program
Matthias E. Liechti
Division of Clinical Pharmacology and Toxicology, University Hospital Basel
The Role of Altered States of Consciousness and Psychedelics in Therapy
Nicola De Pisapia
University of Trento
The Psychedelic Renaissance: a tale of four decades of advancement in science, policy, and culture
Rick Doblin
Multidisciplinary Association for Psychedelic Studies (MAPS)
Exploring the Frontiers: The Science and Therapeutic Potential of Ketamine
Antonio Metastasio, Addiction Treatment Unit Terni, University of Hertfordshire
Michèle Anne Barocchi, Co-founder and executive director MAPS Italia
Microdosing with Psychedelics
Kim Kuypers Maastricht University
How Does It Feel Like to Have a Psychedelic Experience?
Interview with a person with lived experience
Ornella Corazza, University of Trento, University of Hertfordshire
Shanna Marrinan, Chair of the Cannabis Industry Council Research Committee
Page updated
Report abuse